Dr. Billie J. Hall, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Logan Regional Medical Center Emer Dept, 20 Hospital Drive, Logan, WV 25601 Phone: 304-831-1188 Fax: 304-831-1189 |
Beena Nagpal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Logan General Hospital, Logan, WV 25601 Phone: 304-792-1230 |
Dr. James Robert Long Ii, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |
Dr. Jose Y Auditor, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |
Dr. Stephen D Ulaki, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |
Dr. Larry Lucas, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |
Dr. Alberto A Fernandez, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |
News Archive
Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency-associated liver disease (alpha-1 liver disease).
University of Manchester researchers have been awarded £1.6 million to study a group of genes identified as playing a key role in leukaemia.
The advertisements are vague but alluring: Wear insoles and you will be relaxed and stand with proper posture.
The 2009 National Summit on Personalized Health Care: "Fostering Transformative Innovation," marked the formation of the Forum on Personalized Health Care, a collaborative community committed to the development and utilization of transformative innovations in science, technology and health care delivery for the benefit of individuals and families throughout the world.
"In a move that could lead to a new milestone for treatment in the evolution of the worldwide AIDS epidemic," a Food and Drug Administration (FDA) panel on Thursday recommended Gilead Sciences' Truvada as a treatment for preventing HIV infection among healthy people at risk of contracting the virus, Reuters reports, noting, "It already has FDA approval to treat people infected with the human immunodeficiency virus".
› Verified 4 days ago